Study protocol for “MOVEdiabetes”

a trial to promote physical activity for adults with type 2 diabetes in primary health care in Oman

Thamra S. Alghafri, Saud M. Alharthi, Yahya M. Al-Farsi, Angela M. Craigie, Maureen Mcleod, Annie S. Anderson

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Benefits of physical activity in the management of diabetes are well documented. However, evidence on the effectiveness of interventions integrating physical activity in diabetes care is sparse especially in the countries of the Gulf Cooperation Council. The results from this study will increase our understanding of the use of multi-component interventions aimed at increasing physical activity levels in inactive adults with type 2 diabetes in primary health care in Oman. Methods/design: The study is a one year 1:1 cluster randomized controlled trial of the MOVEdiabetes programme (intervention) versus usual care in eight primary health care centres in Oman. The MOVEdiabetes programme utilizes face to face physical activity consultations promoting 150 min of moderate to vigorous physical activity per week (≥600MET-mins/week), pedometers to self-monitor step counts and monthly telephone WhatsApp messages for follow up support. Inactive adults with type 2 diabetes and no contraindication to physical activity will be recruited over a two months period, and followed up for 12 months. To demonstrate a 50% between group difference in physical activity levels (MET-mins/week) over 12 months, (at a power of 80%, and significance level of 5%), 128 participants would be required to complete the study (64 in each arm). Based on a drop-out rate of 20%, 154 participants would require to be recruited (77 in each arm). Assuming a recruitment rate of 70%, 220 potential eligible participants would need to be approached. The primary outcome is change in levels of physical activity measured by the Global Physical Activity Questionnaire. In addition, accelerometers will be used in a sub group to objectively assess physical activity. Secondary outcomes include changes in metabolic and cardiovascular biomarkers, change in self-reported health, social support, self-efficacy for physical activity, and perceived acceptability of the program. All intervention delivery and support costs will be monitored. Discussion: This study will contribute to the evidence on the feasibility, cultural acceptability and efficacy of interventional approaches for increasing physical activity in primary care for persons with type 2 diabetes in Oman. Trial registration: International Standard Randomised Controlled Trials No: ISRCTN14425284 . Registered 12 April 2016.

Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalBMC Public Health
Volume17
Issue number1
DOIs
Publication statusPublished - Jan 6 2017

Fingerprint

Oman
Type 2 Diabetes Mellitus
Primary Health Care
Randomized Controlled Trials
Self Efficacy
Telephone
Social Support
Referral and Consultation
Biomarkers
Costs and Cost Analysis
Health

Keywords

  • Intervention
  • MOVEdiabetes
  • Oman
  • Physical activity
  • Primary health care
  • Type 2 diabetes

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Study protocol for “MOVEdiabetes” : a trial to promote physical activity for adults with type 2 diabetes in primary health care in Oman. / Alghafri, Thamra S.; Alharthi, Saud M.; Al-Farsi, Yahya M.; Craigie, Angela M.; Mcleod, Maureen; Anderson, Annie S.

In: BMC Public Health, Vol. 17, No. 1, 06.01.2017, p. 1-7.

Research output: Contribution to journalArticle

Alghafri, Thamra S. ; Alharthi, Saud M. ; Al-Farsi, Yahya M. ; Craigie, Angela M. ; Mcleod, Maureen ; Anderson, Annie S. / Study protocol for “MOVEdiabetes” : a trial to promote physical activity for adults with type 2 diabetes in primary health care in Oman. In: BMC Public Health. 2017 ; Vol. 17, No. 1. pp. 1-7.
@article{c0a3f452b0e84097b8ccb24f400ed1fc,
title = "Study protocol for “MOVEdiabetes”: a trial to promote physical activity for adults with type 2 diabetes in primary health care in Oman",
abstract = "Background: Benefits of physical activity in the management of diabetes are well documented. However, evidence on the effectiveness of interventions integrating physical activity in diabetes care is sparse especially in the countries of the Gulf Cooperation Council. The results from this study will increase our understanding of the use of multi-component interventions aimed at increasing physical activity levels in inactive adults with type 2 diabetes in primary health care in Oman. Methods/design: The study is a one year 1:1 cluster randomized controlled trial of the MOVEdiabetes programme (intervention) versus usual care in eight primary health care centres in Oman. The MOVEdiabetes programme utilizes face to face physical activity consultations promoting 150 min of moderate to vigorous physical activity per week (≥600MET-mins/week), pedometers to self-monitor step counts and monthly telephone WhatsApp messages for follow up support. Inactive adults with type 2 diabetes and no contraindication to physical activity will be recruited over a two months period, and followed up for 12 months. To demonstrate a 50{\%} between group difference in physical activity levels (MET-mins/week) over 12 months, (at a power of 80{\%}, and significance level of 5{\%}), 128 participants would be required to complete the study (64 in each arm). Based on a drop-out rate of 20{\%}, 154 participants would require to be recruited (77 in each arm). Assuming a recruitment rate of 70{\%}, 220 potential eligible participants would need to be approached. The primary outcome is change in levels of physical activity measured by the Global Physical Activity Questionnaire. In addition, accelerometers will be used in a sub group to objectively assess physical activity. Secondary outcomes include changes in metabolic and cardiovascular biomarkers, change in self-reported health, social support, self-efficacy for physical activity, and perceived acceptability of the program. All intervention delivery and support costs will be monitored. Discussion: This study will contribute to the evidence on the feasibility, cultural acceptability and efficacy of interventional approaches for increasing physical activity in primary care for persons with type 2 diabetes in Oman. Trial registration: International Standard Randomised Controlled Trials No: ISRCTN14425284 . Registered 12 April 2016.",
keywords = "Intervention, MOVEdiabetes, Oman, Physical activity, Primary health care, Type 2 diabetes",
author = "Alghafri, {Thamra S.} and Alharthi, {Saud M.} and Al-Farsi, {Yahya M.} and Craigie, {Angela M.} and Maureen Mcleod and Anderson, {Annie S.}",
year = "2017",
month = "1",
day = "6",
doi = "10.1186/s12889-016-3990-0",
language = "English",
volume = "17",
pages = "1--7",
journal = "BMC Public Health",
issn = "1471-2458",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Study protocol for “MOVEdiabetes”

T2 - a trial to promote physical activity for adults with type 2 diabetes in primary health care in Oman

AU - Alghafri, Thamra S.

AU - Alharthi, Saud M.

AU - Al-Farsi, Yahya M.

AU - Craigie, Angela M.

AU - Mcleod, Maureen

AU - Anderson, Annie S.

PY - 2017/1/6

Y1 - 2017/1/6

N2 - Background: Benefits of physical activity in the management of diabetes are well documented. However, evidence on the effectiveness of interventions integrating physical activity in diabetes care is sparse especially in the countries of the Gulf Cooperation Council. The results from this study will increase our understanding of the use of multi-component interventions aimed at increasing physical activity levels in inactive adults with type 2 diabetes in primary health care in Oman. Methods/design: The study is a one year 1:1 cluster randomized controlled trial of the MOVEdiabetes programme (intervention) versus usual care in eight primary health care centres in Oman. The MOVEdiabetes programme utilizes face to face physical activity consultations promoting 150 min of moderate to vigorous physical activity per week (≥600MET-mins/week), pedometers to self-monitor step counts and monthly telephone WhatsApp messages for follow up support. Inactive adults with type 2 diabetes and no contraindication to physical activity will be recruited over a two months period, and followed up for 12 months. To demonstrate a 50% between group difference in physical activity levels (MET-mins/week) over 12 months, (at a power of 80%, and significance level of 5%), 128 participants would be required to complete the study (64 in each arm). Based on a drop-out rate of 20%, 154 participants would require to be recruited (77 in each arm). Assuming a recruitment rate of 70%, 220 potential eligible participants would need to be approached. The primary outcome is change in levels of physical activity measured by the Global Physical Activity Questionnaire. In addition, accelerometers will be used in a sub group to objectively assess physical activity. Secondary outcomes include changes in metabolic and cardiovascular biomarkers, change in self-reported health, social support, self-efficacy for physical activity, and perceived acceptability of the program. All intervention delivery and support costs will be monitored. Discussion: This study will contribute to the evidence on the feasibility, cultural acceptability and efficacy of interventional approaches for increasing physical activity in primary care for persons with type 2 diabetes in Oman. Trial registration: International Standard Randomised Controlled Trials No: ISRCTN14425284 . Registered 12 April 2016.

AB - Background: Benefits of physical activity in the management of diabetes are well documented. However, evidence on the effectiveness of interventions integrating physical activity in diabetes care is sparse especially in the countries of the Gulf Cooperation Council. The results from this study will increase our understanding of the use of multi-component interventions aimed at increasing physical activity levels in inactive adults with type 2 diabetes in primary health care in Oman. Methods/design: The study is a one year 1:1 cluster randomized controlled trial of the MOVEdiabetes programme (intervention) versus usual care in eight primary health care centres in Oman. The MOVEdiabetes programme utilizes face to face physical activity consultations promoting 150 min of moderate to vigorous physical activity per week (≥600MET-mins/week), pedometers to self-monitor step counts and monthly telephone WhatsApp messages for follow up support. Inactive adults with type 2 diabetes and no contraindication to physical activity will be recruited over a two months period, and followed up for 12 months. To demonstrate a 50% between group difference in physical activity levels (MET-mins/week) over 12 months, (at a power of 80%, and significance level of 5%), 128 participants would be required to complete the study (64 in each arm). Based on a drop-out rate of 20%, 154 participants would require to be recruited (77 in each arm). Assuming a recruitment rate of 70%, 220 potential eligible participants would need to be approached. The primary outcome is change in levels of physical activity measured by the Global Physical Activity Questionnaire. In addition, accelerometers will be used in a sub group to objectively assess physical activity. Secondary outcomes include changes in metabolic and cardiovascular biomarkers, change in self-reported health, social support, self-efficacy for physical activity, and perceived acceptability of the program. All intervention delivery and support costs will be monitored. Discussion: This study will contribute to the evidence on the feasibility, cultural acceptability and efficacy of interventional approaches for increasing physical activity in primary care for persons with type 2 diabetes in Oman. Trial registration: International Standard Randomised Controlled Trials No: ISRCTN14425284 . Registered 12 April 2016.

KW - Intervention

KW - MOVEdiabetes

KW - Oman

KW - Physical activity

KW - Primary health care

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85009960858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009960858&partnerID=8YFLogxK

U2 - 10.1186/s12889-016-3990-0

DO - 10.1186/s12889-016-3990-0

M3 - Article

VL - 17

SP - 1

EP - 7

JO - BMC Public Health

JF - BMC Public Health

SN - 1471-2458

IS - 1

ER -